These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 3339904)
1. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904 [TBL] [Abstract][Full Text] [Related]
2. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401 [TBL] [Abstract][Full Text] [Related]
3. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis. Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181 [TBL] [Abstract][Full Text] [Related]
4. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy. Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048 [TBL] [Abstract][Full Text] [Related]
5. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701 [TBL] [Abstract][Full Text] [Related]
6. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors. Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometric DNA analysis of stage D2 prostatic carcinoma. Yokogi H; Mizutani M; Ishibe T Urol Int; 1991; 47(2):57-9. PubMed ID: 1792707 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA analysis of advanced prostatic adenocarcinoma. Wu WJ; Huang MS; Wang HJ; Chiang PH; Huang CH; Chiang CP Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Mar; 9(3):122-30. PubMed ID: 8510195 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age. Shockley KF; Maatman TJ; Carothers GC; Warzynski MJ Prostate; 1996 Jul; 29(1):46-50. PubMed ID: 8685055 [TBL] [Abstract][Full Text] [Related]
10. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy. Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039 [TBL] [Abstract][Full Text] [Related]
11. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma. Nativ O; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM J Urol; 1990 Aug; 144(2 Pt 1):303-6. PubMed ID: 1695690 [TBL] [Abstract][Full Text] [Related]
13. DNA ploidy and proliferation heterogeneity in human prostate cancers. Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479 [TBL] [Abstract][Full Text] [Related]
15. Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression. The European Organization for Research and Treatment of Cancer Genitourinary Group. van den Ouden D; Tribukait B; Blom JH; Fossa SD; Kurth KH; ten Kate FJ; Heiden T; Wang N; Schroder FH J Urol; 1993 Aug; 150(2 Pt 1):400-6. PubMed ID: 8326563 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometric determination of ploidy in prostatic adenocarcinoma and its relation to clinical outcome. Blatstein LM; Ginsberg PC; Daskal I; Finkelstein LH J Am Osteopath Assoc; 1993 Apr; 93(4):463-8, 471-2. PubMed ID: 8478220 [TBL] [Abstract][Full Text] [Related]
17. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer]. Ishikawa A Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320 [TBL] [Abstract][Full Text] [Related]
18. DNA heterogeneity determined by flow cytometry in prostatic adenocarcinoma--necessitating multiple site analysis. Warzynski MJ; Soechtig CE; Maatman TJ; Goldsmith LC; Grobbel MA; Carothers GG; Shockley KF Prostate; 1995 Dec; 27(6):329-35. PubMed ID: 7501545 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of DNA quantitation in stage D1 prostate carcinoma with the use of image analysis. Peters-Gee JM; Miles BJ; Cerny JC; Gaba AR; Jacobsen G; Crissman JD Cancer; 1992 Sep; 70(5):1159-65. PubMed ID: 1515991 [TBL] [Abstract][Full Text] [Related]
20. Primary squamous cell carcinoma of the male urethra: nuclear deoxyribonucleic acid ploidy studied by flow cytometry. Winkler HZ; Lieber MM J Urol; 1988 Feb; 139(2):298-303. PubMed ID: 3339728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]